نتائج البحث من 41 إلى 50 من أصل 26880 لعبارة Vaginal%2Bcancer
Cancer patients are vulnerable to falls due to muscle loss. ... women of racial minorities to see if this can ... 2-6: 500 mg/m2). Patients randomized to ...
The human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival. Approximately 15-20% of all breast cancers are HER2-positive, which are ...
/ 2:00. Off; English. إظهار النسخة النصية للفيديو Providing tomorrow's breast cancer surgery innovations today. James W. Jakub, M.D., Surgical Oncology, Mayo ...
... cancer, Uterine polyps, Vaginal cancer, Cervical intraepithelial neoplasia grade 3, Ovarian cancer, Lichen sclerosus, Endometrial cancer. إظهار المزيد من ...
Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor ... cancer and pituitary tumors and report our ...
... cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative [HER2, estrogen and progesterone receptor (ER and PR) all ...
... vaginal recurrence among patients with surgical stage I intermediate-risk endometrial cancer. Eligible patients presenting with apparent uterine confined ...
... 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.
... Women With ER/PR+ Metastatic Breast Cancer. Rochester, Minn. This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane ...
... cancer in the cohort of patients undergoing routine surveillance for cancer. The biospecimens will include cultures of tumor cells and tumor-associated non ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.